Home | Business News | Browse by Publication | B | Biotech Business

AGENSYS/GENENTECH SIGN COLLABORATION/LICENSE AGREEMENT.

Publication: Biotech Business
Publication Date: 01-SEP-04 		Format: Online - approximately 385 words
Delivery: Immediate Online Access

Article Excerpt
Agensys, Inc., Santa Monica, Calif., a cancer biotechnology company, has signed an agreement with Genentech Inc. (NYSE: DNA) for the research, development and commercialization of therapeutic and diagnostic products to two of Agensys' proprietary cancer targets. The agreement provides Genentech with exclusive worldwide licenses under Agensys' patent rights for the development of specified therapeutic products and...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Business
ALEXION REACHES AGREEMENT WITH FDA FOR PHASE III ECULIZUMAB., September 01, 2004
POWER3 GETS RIGHTS TO NEURODEGENERATIVE DISEASE BLOOD TEST., September 01, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.